Dr. Anoop Hajare has over 3 years of experience in medico-marketing at Mylan Pharmaceuticals and Glenmark Pharmaceuticals. At Mylan, he helped launch several women's health products and led scientific activities including advisory panels and CME events. He provided medical support, trained field staff, and developed legal agreements. Previously at Glenmark, he supported multiple product launches and conducted various studies. Dr. Hajare aims to take on a challenging and prospective role in medico-marketing that encourages constant learning and exposure to new trends.
Stanford immunomodulators for treatment of covid19 - brandon jonseckBrand Jonseck
Brandon Jonseck completed this activity on 11/20/2020 through Stanford Medical School.
Overview
Internet Enduring Material sponsored by the Stanford University School of Medicine. Presented by the Department of Medicine at the Stanford University School of Medicine.
Experts discuss the use of immunomodulator therapies for treatment of COVID-19. Discussed hospital updates, Medical Staff updates. Flu vaccination requirements for staff shared. Preparations are in place for the respiratory virus season. Rapid testing requirements. Other topics discussed include immunomodulators for treatment of COVID-19. Talked about Tocilizumab trial for the treatment of COVID-19, NIH ACTT trial and Blaze 1 trial. Also discussed the WHO Solidarity Trial. Remdesivir is the first FDA approved treatment for COVID-19. Describe the strategy for ongoing BLAZE-1 clinical trial.
Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours)
Target Audience
Specialties - All Specialties
Objectives
At the conclusion of this activity, participants should be able to:
Evaluate current clinical trials taking place in order to determine the effectiveness of immunomodulators for treating COVID-19 in the near future.
Accreditation
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Patient satisfaction and side effects in primary care: An observational study...home
Overall patient satisfaction was significantly higher in homeopathic than in
conventional care. Homeopathic treatments were perceived as a low-risk therapy with two to
three times fewer side effects than conventional care
‘Experience is the best teacher”
Now, at the end of Hospital Training, I am pleading to say that NIRMA UNIVERSITY has intellectually included Hospital Training as part of B.Pharm. Hons. ‗S academic curriculum (Semester X). This hospital training has given me a chance to get exposed to practical work. What I have studied in semester 9, I have able to implement it in semester X hospital training.
I have already completed B.Pharm. And have studied subjects like Pharmaceutics, Pharmacognosy, etc. But in this course, I have been exposed to clinical field, not only theoretical aspect, but practical aspect as well which, according to me, the most exciting experience of my field is. According to my merit rank (calculated on the basis of semester 9 marks); I have got a chance to get trained in Shrey Hospital under the guidance of Dr. Chirag Joshi sir. He is the one who holds and manages the Intensive Coronary Care Unit (I.C.C.U) on one hand alone. It has been great experience to obtaining under such qualified and experienced person.
On the first day of my training, I along with fellow members was introduced to medical staff and have been introduced to different departments like ICCU, Operation theatre, dialysis unit, Radiology department, Pathology Lab, Lithotripsy, Pharmacy and various wards and these sessions were included in week one schedule.
During second week, I was allocated to pharmacy. I got exposed to the way to handle prescription and reading as well. I came to know the arrangement of medicines. Different medicines of same company were kept in one shelf and were arranged according to their alphabetical order in the same shelf. I also came to know about medication handling & storage, dispensing, ADR and medication order identification while handling prescription. By this pharmacy experience I came to know about extreme use of antibiotics i.e. irrational use we can say. Pharmacists here in pharmacy have overcome the mistakes done by doctor in hurry e.g. dose, freq.etc.
Our case studies began third week onwards and were continued till the end of training. Herein I studied different cases pertaining to most of the system of body. Dr. Chirag sir explained us the format of presenting the case like Patient demographics,chief complains, past history, past medication history, vital signs, systemic examination, laboratory investigation, other diagnostic tests (X-ray, USG, and MRI), medications, adverse reactions and then other related discussions. Sir explained us how to take history of patient and assigned me the case along with other fellow members which we have to present before him on the next day by preparing in the format what he had taught to us. Sir fully explains us the case according to format and carries on interaction as well. This include why a particular treatment is preferred (based on patient‘s economic status), how to overcome drug interactions and ADRs. He fully explains the treatment along with the available options of medicines e.g. Cephalosporins. He gives us a brief introduction over different class of the same along with brand names and the spectrum they cover. He explained all the part of case from entering in the hospital to discharge from hospital, every reason for single treatment. And I also saw some cases of particular of my interest like poisoning, alcoholic patient, renal failure.
During this practical training I also involved in ward round participation. I used to go with Chirag sir and learn the way treat the patient and maintain patient history notes. I used to check drug dose and dosing frequency. I also used to take patient history which is also critical in understanding patient‘s case. During ward round participation, I came to real practice experience as I was in front of the patient and use knowledge in dealing with patient.
All in all, it was the best experience that I have undergone in my field. This would be greater than anything in clearing my future registered pharmacist exam i
Austin Journal of Medical Oncology is an open access, peer review journal publishing original research & review articles in all the fields of Medical Oncology. Medical Oncology is the branch of medicine which deals with cancer and tumor related problems. Austin Journal of Medical Oncology provides a new platform for all researchers, scientists, scholars, students to publish their research work & update the latest research information.
Austin Journal of Medical Oncology is a comprehensive Open Access peer reviewed scientific Journal that covers multidisciplinary fields. We provide limitless access towards accessing our literature hub with colossal range of articles. The journal aims to publish high quality varied article types such as Research, Review, Short Communications, Case Reports, Perspectives (Editorials), Clinical Images.
Austin Journal of Medical Oncology supports the scientific modernization and enrichment in Medical Oncology research community by magnifying access to peer reviewed scientific literary works. Austin also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Harmonizing Healthcare Financing for Health Equity: Case Studies of Cross-sub...Borwornsom Leerapan
Harmonizing Healthcare Financing for Health Equity: Case Studies of Cross-subsidization in Thai Public Hospitals. Presented in Joint Conference of Medical Sciences Chula-Rama-Siriraj (JCMS2015) 2015.6.6
Stanford immunomodulators for treatment of covid19 - brandon jonseckBrand Jonseck
Brandon Jonseck completed this activity on 11/20/2020 through Stanford Medical School.
Overview
Internet Enduring Material sponsored by the Stanford University School of Medicine. Presented by the Department of Medicine at the Stanford University School of Medicine.
Experts discuss the use of immunomodulator therapies for treatment of COVID-19. Discussed hospital updates, Medical Staff updates. Flu vaccination requirements for staff shared. Preparations are in place for the respiratory virus season. Rapid testing requirements. Other topics discussed include immunomodulators for treatment of COVID-19. Talked about Tocilizumab trial for the treatment of COVID-19, NIH ACTT trial and Blaze 1 trial. Also discussed the WHO Solidarity Trial. Remdesivir is the first FDA approved treatment for COVID-19. Describe the strategy for ongoing BLAZE-1 clinical trial.
Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours)
Target Audience
Specialties - All Specialties
Objectives
At the conclusion of this activity, participants should be able to:
Evaluate current clinical trials taking place in order to determine the effectiveness of immunomodulators for treating COVID-19 in the near future.
Accreditation
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Patient satisfaction and side effects in primary care: An observational study...home
Overall patient satisfaction was significantly higher in homeopathic than in
conventional care. Homeopathic treatments were perceived as a low-risk therapy with two to
three times fewer side effects than conventional care
‘Experience is the best teacher”
Now, at the end of Hospital Training, I am pleading to say that NIRMA UNIVERSITY has intellectually included Hospital Training as part of B.Pharm. Hons. ‗S academic curriculum (Semester X). This hospital training has given me a chance to get exposed to practical work. What I have studied in semester 9, I have able to implement it in semester X hospital training.
I have already completed B.Pharm. And have studied subjects like Pharmaceutics, Pharmacognosy, etc. But in this course, I have been exposed to clinical field, not only theoretical aspect, but practical aspect as well which, according to me, the most exciting experience of my field is. According to my merit rank (calculated on the basis of semester 9 marks); I have got a chance to get trained in Shrey Hospital under the guidance of Dr. Chirag Joshi sir. He is the one who holds and manages the Intensive Coronary Care Unit (I.C.C.U) on one hand alone. It has been great experience to obtaining under such qualified and experienced person.
On the first day of my training, I along with fellow members was introduced to medical staff and have been introduced to different departments like ICCU, Operation theatre, dialysis unit, Radiology department, Pathology Lab, Lithotripsy, Pharmacy and various wards and these sessions were included in week one schedule.
During second week, I was allocated to pharmacy. I got exposed to the way to handle prescription and reading as well. I came to know the arrangement of medicines. Different medicines of same company were kept in one shelf and were arranged according to their alphabetical order in the same shelf. I also came to know about medication handling & storage, dispensing, ADR and medication order identification while handling prescription. By this pharmacy experience I came to know about extreme use of antibiotics i.e. irrational use we can say. Pharmacists here in pharmacy have overcome the mistakes done by doctor in hurry e.g. dose, freq.etc.
Our case studies began third week onwards and were continued till the end of training. Herein I studied different cases pertaining to most of the system of body. Dr. Chirag sir explained us the format of presenting the case like Patient demographics,chief complains, past history, past medication history, vital signs, systemic examination, laboratory investigation, other diagnostic tests (X-ray, USG, and MRI), medications, adverse reactions and then other related discussions. Sir explained us how to take history of patient and assigned me the case along with other fellow members which we have to present before him on the next day by preparing in the format what he had taught to us. Sir fully explains us the case according to format and carries on interaction as well. This include why a particular treatment is preferred (based on patient‘s economic status), how to overcome drug interactions and ADRs. He fully explains the treatment along with the available options of medicines e.g. Cephalosporins. He gives us a brief introduction over different class of the same along with brand names and the spectrum they cover. He explained all the part of case from entering in the hospital to discharge from hospital, every reason for single treatment. And I also saw some cases of particular of my interest like poisoning, alcoholic patient, renal failure.
During this practical training I also involved in ward round participation. I used to go with Chirag sir and learn the way treat the patient and maintain patient history notes. I used to check drug dose and dosing frequency. I also used to take patient history which is also critical in understanding patient‘s case. During ward round participation, I came to real practice experience as I was in front of the patient and use knowledge in dealing with patient.
All in all, it was the best experience that I have undergone in my field. This would be greater than anything in clearing my future registered pharmacist exam i
Austin Journal of Medical Oncology is an open access, peer review journal publishing original research & review articles in all the fields of Medical Oncology. Medical Oncology is the branch of medicine which deals with cancer and tumor related problems. Austin Journal of Medical Oncology provides a new platform for all researchers, scientists, scholars, students to publish their research work & update the latest research information.
Austin Journal of Medical Oncology is a comprehensive Open Access peer reviewed scientific Journal that covers multidisciplinary fields. We provide limitless access towards accessing our literature hub with colossal range of articles. The journal aims to publish high quality varied article types such as Research, Review, Short Communications, Case Reports, Perspectives (Editorials), Clinical Images.
Austin Journal of Medical Oncology supports the scientific modernization and enrichment in Medical Oncology research community by magnifying access to peer reviewed scientific literary works. Austin also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Harmonizing Healthcare Financing for Health Equity: Case Studies of Cross-sub...Borwornsom Leerapan
Harmonizing Healthcare Financing for Health Equity: Case Studies of Cross-subsidization in Thai Public Hospitals. Presented in Joint Conference of Medical Sciences Chula-Rama-Siriraj (JCMS2015) 2015.6.6
Regular review and monitoring of product information for medicines is important, to support awareness of relevant updates/changes which may affect prescribing, dispensing, administration or monitoring practices.
1. 1
Dr. Anoop Hajare
MBBS. M.D. (Pharmacology)
Contact No. 07022608018
Email id: anoophajare@gmail.com
OBJECTIVES:
Taking up a challenging and prospective job in Medico marketing that encourages innovation,
constant learning, and ensures exposure to evolving trends.
EDUCATION:
THESIS:
Drug utilization study of antihypertensive drugs
A prospective, cross sectional study monitoring the utilization of antihypertensive drugs, FDCs
and comparison of the same with the standard guidelines (JNC 7). The prescribed daily doses
were compared with the defined daily doses as recommended by WHO
Total Experience: Over 3 years
PRESENT APPOINTMENT:
02nd April 2015 onwards till date: Working at Mylan Pharmaceuticals Pvt. Ltd. as Medical
Advisor handling Women’s Health division (Prescription and Infertility teams)
Activities done:
At Mylan: 02nd April 2015 till Date –
Launch:
AdD3 2K/60K (Vitamin D3)
Examination Passed Year Of
Passing
Board/
University
School/ College Percentage
M.D. Pharmacology Nov
2012
KIMS University,
Karad
Krishna Institute of Medical
Sciences, Karad
(Maharashtra)
60%
MBBS March
2005
Rajiv Gandhi
University of
Health Sciences
KBNIMS, Gulbarga
(Karnataka)
61.1%
2. 2
Contraceptive solutions (Famycare Women’s Health Business) – OCPs
Famycept
Descon
Yanci
Frewil
Visna Relaunch
Scientific Activities:
3 Advisory Panel Meetings – Bangalore, Hyderabad & Mumbai
7 Colloquium Meetings (Integrated CMEs) – Bangalore, Chennai, Delhi, Hyderabad,
Mumbai, Ahmedabad, Kolkata in 3 days involving Oncology, Hepatology and HIV BUs
Mylan initiated and third party CMEs and Awareness campaigns
Medical Support to Business:
Development and approval of e-Visual Aid (Quarterly input) – Menopause, OCPs,
Infertility, Antenatal care
Presentations for OCP launch activities in CMEs/RTMs
HRT Compendiums (Quarterly input)
Fertility and Sterility Review articles (Quarterly input)
Rationale/PI/AbPI: New product launch/FDCs
Article abstracts, links to full texts, power-point presentations, LBLs, Posters, newspaper
articles etc.
Resolving queries, New product evaluation
Prepared questionnaires to gain insights from KOLs
WoApp Launch: A unique mobile application to increase awareness related to women’s
health for android and iPhone users
Developing sound communication plan
Field work – 40 days on field
KOL Engagement: 33 doctors engaged in Advisory Panel Meetings, 400 doctors engaged
in Colloquium Event apart from engagement in Mylan CMEs
Field Force Training
Conducted training for India team (Prescription + Infertility teams)
Product training for OCPs (Launch and induction for new joiners)
Training via e-learning modules (once a month along with questionnaires)
Monthly training on promotional inputs
3. 3
Refresher training programs and workshops during cycle meetings
Training the field force on the SOPs and Good Clinical Practices (Role plays)
Developed Legal contracts/speakership & consultancy agreements for KOLs
Assisted the PV team to obtain required details w.r.t to Adverse Events
At Glenmark: 19th December 2012 to 1st April 2015 –
Launch:
Majesta Division (Acute therapy):
Ascoril LS Drops (Cough Preparation)
Ascoril LS+ Syrup (Cough Preparation)
Zinox (Garenoxacin – Newer Fluoroquinolone, 1st time launch in India)
Gutspert (Bacillus clausii) Probiotic
Bon D Light Drops (Vitamin D Drops)
Ascoril Flu Kidz Syrup (Cough Preparation)
Ascoril D Junior Syrup (Cough Preparation)
G&G Division (Gynecology & Infertility)
Dubagest SR (Oral Natural Micronized Progesterone)
Milical OD3 (Calcium and Vitamin D FDC)
Mumfer D3 (Iron plus Folic acid FDC)
Prepared Monographs, PIs, AbPIs, Training Manuals, VAFs for new launches
Rolled out Prescription event monitoring (PEM) Studies for Dubagest SR 300/400,
Altacef/Altacef CV, Azifine, Zinox, Mumfer XT, Mumfer D3, Azifine
Rolled out Market Research Survey (MRS) studies for Altacef, Azifine L, Zinox
Initiated POEM Survey for Ascoril LS+, Altacef suspension
Investigator Initiated Study for Dubagest SR 300 in IUI/ART cycles
Conducted National and State Level Advisory Boards Meetings, CMEs, RTMs for Dubagest SR
300/400, Zinox
Conducted State level Gynoscience CME meetings for the products Mumfer XT, Mumfer D3,
Milical OD3 – Newer roles and evolving concepts
Drafted Executive Summary documents to DCG(I) for PMS Study and indication expansion
for Zinox
Extensive literature support from latest indexed journals for various promotional materials.
Published case study reports, invitro profile study and PEM studies (Original articles) on
Zinox to National and International Journals
4. 4
Handling of queries from the KOLs, Sales and Marketing teams
Drafted various CME slides to KOLs
Routine training and Web based training for the Sales team
Prepared Rationales for various FDCs for the upcoming NDAC presentations with DCG(I)
Communications in the form of detailers, news prints, article reprints, detailers, case study
reports etc.
Job Purpose:
To provide strategic and operational medical inputs including medical information and product
support to marketing in order to achieve Mylan Pharma’s India business objectives.
Key Responsibilities:
Medico-Marketing Activities
o Launch preparations – search of relevant literature, discussion about
positioning, USP of the proposed molecules, preparation of product
monograph/booklet, launch training of field
o VAF Discussion (Structured communication), other scientific
communications going to field as per the Glenmark promotional practice
guidelines.
o Review of scientific literature, journals, medical books, etc for doctors
communication as per the Glenmark promotional practice guidelines.
o Organizing Offshore Scientific Meet (Selection of topic, identification of
speakers, moderators, identification of location & suggestion the same to
marketing, etc)
o Conducting CMEs and Workshops at various venues including teaching
institutes
o Presentations to be made on newer products at various CMEs, Workshops and
Symposias
o Handling field query (either from doctor or sales representative) through
mail, directly via phone
o Robust support to training department so as to build up confident sales team
Medical Activities
o Conduction of clinical trials (post-marketing, promotional and PEM studies) -
Identification of investigator, site, working out logistics for the CTs, follow up
of successful completion of study
o Preparation of package insert
o Preparation of product monographs
o Conduction of scientific workshops (identification of speaker, topic, etc)
o Conduction of local forums, round table meets, local CMEs, symposiums, etc
o Refresher training of the field staff on a periodic basis
5. 5
o Directing the preparation of scientific movies, etc to be used for CMEs, case
discussions, etc
o Medical evaluations of new products, new formulations
o Development of product rationale for DCGI
o Maintaining customer relations with various KOLs and Trend Setters and
continuously updating the list
o Pharmacovigilance activities
Medical Research
o Identification of potential molecules for the division, suggestion of new
formulation (brand extensions)
o Meeting doctors (KOLs) to identify any unmet need in therapy, suggestion for
new formulation
o Evaluations of products/formulations etc proposed for in licensing,
marketing, etc
o Suggestions for the formulation changes in the current treatment options for
the New Drug Development Projects.
o Planning of workshops for respective divisions including co-ordinating with
the KOLs and the hospitals conducting the same.
o Co-ordination with the Business Development Team for the introduction of
newer molecules and in-licencing opportunities.
o Co-ordination with the IP Team for the patent opportunities for the newer
formulations through NDDS projects
PAST APPOINTMENTS:
19th Dec 2012 to 1st April 2015: Worked at Glenmark Pharmaceuticals, Mumbai as Medical
Advisor for Majesta and G&G divisions
Post-graduation in MD Pharmacology Resident trainee, Worked as Tutor for 3 years in the
department of pharmacology, Krishna Institute of Medical College, KIMS University, Karad,
Maharashtra.
Teaching Undergraduate medical, dental, physiotherapy and nursing students in
theory lectures and practical sessions in the laboratory
Seminar presentations weekly, Journal club discussions, Animal drug experiments,
Dissertation, Projects and Paper presentations.
ADR reporting, Drug prescription audits of various clinical departments.
Worked to initiate other animal experiments which were not a routine in the
university.
Animal house administration and maintenance.
Drug stock checking at Krishna Hospital, Karad
Worked as Tutor in the department of Community Medicine from 15th November 2006 to 10th
January in Navodaya Medical College, Raichur, Rajiv Gandhi University of Health Sciences,
Karnataka.
WORKSHOPS/CONFERENCES/TRAINING ATTENDED:
6. 6
Conference on “Medical Writing” conducted at Seth GS Medical College & KEM Hospital,
Mumbai organized by JPGM WRITECON in December 2009.
Conference on “Spinal cord and peripheral nerve disorders" held at KIMS University, Karad
On 2nd May 2010.
“International conference on clinical trials” organized by CII in association with DST, QCI and
ACRO at Mumbai in November 2010.
“43rd Annual conference of Indian Pharmacological Society” organized by National Executive
Committee held at Hyderabad in December 2010.
“1st Interdisciplinary Research Conference” held at KIMS, Karad in February 2011.
National Symposium on Pharmacovigilance held on 12th April 2011 at department of
pharmacology JNMC, KLE University, Belgaum
“Stress management workshop” held at KIMS, Karad in 19th August 2011.
NAPCON 2014 conference held at Agra
AICOG 2016 conference held at Agra
Extra-Curricular Activities:
Represented Rajiv Gandhi University of Health Sciences, Karnataka in South Zone Inter
University Cricket Tournament held at Manipal Academy of Higher Education – Manipal during
the year 2005-2006 (University Blue)
Represented KBN Medical College in Karnataka Zonal Cricket tournament 2001 to 2005.
Participated in the RGUHS intercollegiate cultural and literary meet KSHITIJ held at JNMC,
Belgaum from 24th to 26th November 2003
Publications:
1. Garenoxacin in skin & skin structure infections complicated by bear bite (2nd Author; Case
study)
2. Garenoxacin in skin & skin structure infections sustained due to road traffic accident (2nd
Author; Case study)
3. Garenoxacin in difficult to treat lung abscess – A case study report (2nd Author; Case
study)
4. Garenoxacin in uncomplicated urinary tract infection – A case study report (3rd Author;
Case study)
5. Prescription event monitoring study to assess the safety profile of oral natural micronized
progesterone sustained release in India (2nd Author; Short communication)
6. Open-label observational study to determine the success rate of first cycle intrauterine
insemination (IUI) involving luteal phase support with oral natural or synthetic
progesterone (Corresponding Author; Original/Research Article)
7. Garenoxacin in the treatment of Community-acquired pneumonia (CAP) (2nd Author; Case
study)
8. Open-label, randomized, crossover comparative bioavailability study of cefixime from two
tablet formulations after single oral administration (2nd Author; Original/Research
Article)
7. 7
9. Post-Approval, Observational Study with Garenoxacin a newer des-fluoroquinolone in
uncomplicated urinary tract infections in Vadodara, India (2nd Author;
Original/Research)
10. A prescription event monitoring (PEM) study on the utility of Garenoxacin, a newer
fluoroquinolone in India (1st Author: Original/Research)
11. Survival or safety: Balancing act with Colistin (4th Author; Expert commentary; Accepted)
Kindly click on the link given below to follow the citation details
https://scholar.google.co.in/citations?hl=en&user=iEF6nwkAAAAJ&view_op=list_works&sortby=p
ubdate. Accessed on 04/01/2016
Paper Presentations:
1. Oral presentation at NAPCON (National conference of Pulmonary Diseases – Indian Chest
society & National College of Chest Physicians) – 2014 conference held at Agra on “A
prescription event monitoring (PEM) study on the utility of Garenoxacin, a newer
fluoroquinolone in India”
2. Presented a research paper at “2nd interdisciplinary conference” at KIMS University, Karad in
March 2012
Personal Attributes:
Hardworking, reliable and dedicated
Enthusiastic and keen to learn
Able to work both independently and in a team
Highly motivated and career-oriented, committed to continuous self-appraisal
Good communication skills
Well versed with the Medical literature search
Computer Proficiency:
Well versed with Microsoft Office (Word, Excel, Outlook and Power Point) and Web based
learning.
Personal Information:
Date of Birth : 19th August 1981
Marital status : Single
Passport : Yes
Languages : English, Hindi, Kannada, Marathi, Urdu
Hobbies : Sports (Cricket, Badminton, Table Tennis, Swimming),
Listening music, Travelling and making new friends